“Huge Opportunity”: BofA Starts Coverage on Nebius with Buy Rating
Bank of America initiates coverage on Nebius with a Buy rating and $150 price target, implying 31% upside.
Already have an account? Sign in.
Bank of America initiates coverage on Nebius with a Buy rating and $150 price target, implying 31% upside.
Rocket Lab was awarded a $266M contract by the U.S. Space Systems Command for 12 suborbital missions from Alaska, with completion targeted by 2028.
Celldex discontinues barzolvolimab development in prurigo nodularis after its Phase 2 study failed to meet the primary endpoint and key secondary endpoints.
Super Micro expects gross margins nearly double previous guidance at 15-17%. Strong AI demand pushes backlog to record levels.